EMA to Update Transparency Plan With CCI Redaction Criteria

Drug Industry Daily
A A
The European Medicines Agency plans to move forward with a controversial clinical trial transparency plan, but with new added redaction features to remove trial data that could allow companies to steal commercially confidential information.

To View This Article:

Login

Subscribe To Drug Industry Daily